Market Place
Sourcing Support
All News #Library
Others
Akebia Therapeutics, Keryx Biopharms Announce Chairperson for Combined Company
16 Nov 2018 //
BUSINESSWIRE
Wolf Popper Investigates the Proposed Acq of Keryx Biopharmaceuticals by Akebia
23 Jul 2018 //
PR NEWSWIRE
Bragar Eagel & Squire, is Investigating the Board of Directors of Keryx
02 Jul 2018 //
GLOBENEWSWIRE
Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company
02 Jul 2018 //
HEALTHCARE GLOBAL
Akebia, Keryx to merge, creating kidney disease specialist
29 Jun 2018 //
FIERCE BIOTECH
Akebia & Keryx to Merge, Creating a Fully Integrated Company Kidney Disease
28 Jun 2018 //
PRESS RELEASE
Keryx Announces Data from an Investigator Sponsored Trial of Ferric Citrate
25 May 2018 //
PRESS RELEASE
Keryx Announces that Auryxia® is Now on Formulary Medicare Part D Plans
01 May 2018 //
PRESS RELEASE
Keryx Announces Pub of Data from the Phase 3 Trial of Auryxia® ferric citrate
04 Apr 2018 //
PRESS RELEASE
USFDA Approves Auryxia® Tablets as Treatment for People Iron Deficiency Anemia
07 Nov 2017 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.